Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

MetroCorp Bancshares Q2 Profit Rises - Quick Facts

MetroCorp Bancshares Inc. (MCBI: Quote) reported that its second-quarter net income applicable to common stock was $2.8 million, compared to $2.5 million in the year-ago period. Earnings per share for the quarter was $0.15, down from $0.16 in the comparable quarter last year.

On average, three analysts polled by Thomson Reuters expected the company to earn $0.15 per share for the quarter. Analysts' estimates typically exclude special items.

Net interest income for the latest second quarter was $12.98 million, down 4.9% compared with $13.65 million in the year-ago period, while total non-interest income rose 10.5% to $1.9 million from $1.8 million in the prior year quarter.

The decrease in net interest income was primarily due to a decline in the yield on loans, partially offset by lower cost of deposits.

Click here to receive FREE breaking news email alerts for MetroCorp Bancshares Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office. After coming under pressure in early trading, stocks have seen some further downside over the course of the trading day on Friday. With the losses on the day, the S&P 500 is pulling back well off the record closing high that it set in the previous session.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.